This malignancy is sent from your clinic to oncology and an FDA approved therapy is initiated. What is the target of this medication?
A. PD-1 receptor on tumor cells
B. PD-1 receptor on T cells
C. PD-L1 receptor on tumor cells
D. PD-L1 receptor on T cells
E. CTLA-4 receptor on tumor cells
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.